» Articles » PMID: 24887793

The Impact of Regionalization of Pancreaticoduodenectomy for Pancreatic Cancer in North Carolina Since 2004

Overview
Journal Am Surg
Specialty General Surgery
Date 2014 Jun 3
PMID 24887793
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Pancreaticoduodenectomy (PD) carries a significant risk. High-volume centers (HVCs) provide improved outcomes and regionalization is advocated. Rapid regionalization could, however, have detrimental effects. North Carolina has multiple HVCs, including an additional HVC added in late 2006. We investigated regionalization of PD and its effects before, and after, the establishment of this fourth HVC. The North Carolina Hospital Discharge Database was queried for all PDs performed during 2004 to 2006 and 2007 to 2009. Hospitals were categorized by PD volume as: low (one to nine/year), medium (10 to 19/year), and high (20/year or more). Mortality and major morbidity was assessed by comparing volume groups across time periods. Number of PDs for cancer increased 91 per cent (129 to 246 cases) at HVCs, whereas decreasing at low-volume (62 to 58 cases) and medium-volume (80 to 46 cases) centers. Percentage of PD for cancer performed at HVCs increased significantly (47.6 to 70.3%) while decreasing for low- and medium-volume centers (P < 0.001). Mortality was significantly less at HVCs (2.8%) compared with low-volume centers (10.3%) for 2007 to 2009. Odds ratio for mortality was significantly lower at HVCs during 2004 to 2006 (0.31) and 2007 to 2009 (0.34). Mortality for PD performed for cancer decreased from 6.6 to 4.6 per cent (P = 0.31). Major morbidity was not significantly different between groups within either time period; however, there was a significant increase in major morbidity at low-volume centers (P = 0.018). Regionalization of PD for cancer is occurring in North Carolina. Mortality was significantly lower at HVCs, and rapid regionalization has not detracted from the superior outcomes at HVCs.

Citing Articles

Regionalization of pancreatic surgery in California: Benefits for preventing postoperative deaths and reducing healthcare costs.

Perry L, Canter R, Gaskill C, Bold R Surg Open Sci. 2023; 16:198-204.

PMID: 38076574 PMC: 10709075. DOI: 10.1016/j.sopen.2023.11.004.


Role of intraoperative processes of care during major upper gastrointestinal oncological resection in postoperative outcomes: a scoping review protocol.

Rajendran L, Hopkins A, Hallet J, Sinha R, Tanwani J, Kao M BMJ Open. 2023; 13(7):e068339.

PMID: 37407044 PMC: 10335411. DOI: 10.1136/bmjopen-2022-068339.


Hospital Designations and Their Impact on Guideline-Concordant Care and Survival in Pancreatic Cancer. Do They Matter?.

Murimwa G, Karalis J, Meier J, Yan J, Zhu H, Hester C Ann Surg Oncol. 2023; 30(7):4377-4387.

PMID: 36964844 DOI: 10.1245/s10434-023-13308-7.


Is Improved Survival in Early-Stage Pancreatic Cancer Worth the Extra Cost at High-Volume Centers?.

Perry L, Bateni S, Bold R, Hoch J J Am Coll Surg. 2021; 233(1):90-98.

PMID: 33766724 PMC: 8272961. DOI: 10.1016/j.jamcollsurg.2021.02.014.


Regional oncology network between pancreatic centers safeguards waiting times for pancreatoduodenectomy.

Steen M, van Vliet C, Festen S, Besselink M, Gerhards M, Busch O Updates Surg. 2019; 71(4):645-651.

PMID: 31506895 PMC: 6892758. DOI: 10.1007/s13304-019-00677-6.